Lexicon Announces Telotristat Etiprate Data To Be Presented At European Cancer Congress
August 26, 2015 at 08:02 AM EDT
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from its pivotal TELESTAR Phase 3 clinical study of telotristat ...
